位置:首页 > 蛋白库 > FYB2_HUMAN
FYB2_HUMAN
ID   FYB2_HUMAN              Reviewed;         728 AA.
AC   Q5VWT5; Q63HM3; Q6ZUY6;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   03-AUG-2022, entry version 132.
DE   RecName: Full=FYN-binding protein 2 {ECO:0000312|HGNC:HGNC:27295};
DE   AltName: Full=Activation-dependent, raft-recruited ADAP-like phosphoprotein {ECO:0000303|PubMed:27335501};
GN   Name=FYB2 {ECO:0000312|HGNC:HGNC:27295};
GN   Synonyms=ARAP {ECO:0000303|PubMed:27335501}, C1orf168;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, PHOSPHORYLATION AT TYR-491 AND TYR-587, INTERACTION WITH LCP2;
RP   SKAP1; LCK AND FYN, AND MUTAGENESIS OF TYR-491 AND TYR-587.
RX   PubMed=27335501; DOI=10.4049/jimmunol.1501913;
RA   Jung S.H., Yoo E.H., Yu M.J., Song H.M., Kang H.Y., Cho J.Y., Lee J.R.;
RT   "ARAP, a novel adaptor protein, is required for TCR signaling and integrin-
RT   mediated adhesion.";
RL   J. Immunol. 197:942-952(2016).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
CC   -!- FUNCTION: Adapter protein that plays a role in T-cell receptor (TCR)-
CC       mediated activation of signaling pathways. Required for T-cell
CC       activation and integrin-mediated T-cell adhesion in response to TCR
CC       stimulation (PubMed:27335501). {ECO:0000269|PubMed:27335501}.
CC   -!- SUBUNIT: Interacts with SKAP1, LCK and FYN. The phosphorylated form
CC       interacts with LCP2. {ECO:0000269|PubMed:27335501}.
CC   -!- SUBCELLULAR LOCATION: Membrane raft {ECO:0000269|PubMed:27335501}.
CC       Note=Recruited to membrane rafts and immunological synapse after TCR
CC       stimulation. {ECO:0000269|PubMed:27335501}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5VWT5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5VWT5-2; Sequence=VSP_028031, VSP_028032;
CC   -!- TISSUE SPECIFICITY: Expressed in T-cells (at protein level). Widely
CC       expressed. {ECO:0000269|PubMed:27335501}.
CC   -!- PTM: Phosphorylation is required for its function in T-cell activation.
CC       {ECO:0000269|PubMed:27335501}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK125198; BAC86080.1; -; mRNA.
DR   EMBL; BX648439; CAH56148.1; -; mRNA.
DR   EMBL; AL035705; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360295; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS30729.1; -. [Q5VWT5-1]
DR   RefSeq; NP_001004303.3; NM_001004303.4. [Q5VWT5-1]
DR   AlphaFoldDB; Q5VWT5; -.
DR   SMR; Q5VWT5; -.
DR   BioGRID; 128284; 10.
DR   IntAct; Q5VWT5; 1.
DR   STRING; 9606.ENSP00000345972; -.
DR   iPTMnet; Q5VWT5; -.
DR   PhosphoSitePlus; Q5VWT5; -.
DR   BioMuta; FYB2; -.
DR   DMDM; 74747442; -.
DR   EPD; Q5VWT5; -.
DR   MassIVE; Q5VWT5; -.
DR   PaxDb; Q5VWT5; -.
DR   PeptideAtlas; Q5VWT5; -.
DR   PRIDE; Q5VWT5; -.
DR   ProteomicsDB; 65558; -. [Q5VWT5-1]
DR   ProteomicsDB; 65559; -. [Q5VWT5-2]
DR   Antibodypedia; 33247; 54 antibodies from 11 providers.
DR   DNASU; 199920; -.
DR   Ensembl; ENST00000343433.7; ENSP00000345972.6; ENSG00000187889.13. [Q5VWT5-1]
DR   GeneID; 199920; -.
DR   KEGG; hsa:199920; -.
DR   MANE-Select; ENST00000343433.7; ENSP00000345972.6; NM_001004303.5; NP_001004303.3.
DR   UCSC; uc001cym.5; human. [Q5VWT5-1]
DR   CTD; 199920; -.
DR   DisGeNET; 199920; -.
DR   GeneCards; FYB2; -.
DR   HGNC; HGNC:27295; FYB2.
DR   HPA; ENSG00000187889; Tissue enhanced (choroid plexus, fallopian tube, liver).
DR   MIM; 618478; gene.
DR   neXtProt; NX_Q5VWT5; -.
DR   OpenTargets; ENSG00000187889; -.
DR   PharmGKB; PA142672418; -.
DR   VEuPathDB; HostDB:ENSG00000187889; -.
DR   eggNOG; ENOG502RXZD; Eukaryota.
DR   GeneTree; ENSGT00530000063460; -.
DR   HOGENOM; CLU_023222_0_0_1; -.
DR   InParanoid; Q5VWT5; -.
DR   OMA; KPWKNFP; -.
DR   OrthoDB; 343643at2759; -.
DR   PhylomeDB; Q5VWT5; -.
DR   TreeFam; TF337003; -.
DR   PathwayCommons; Q5VWT5; -.
DR   SignaLink; Q5VWT5; -.
DR   BioGRID-ORCS; 199920; 7 hits in 1054 CRISPR screens.
DR   ChiTaRS; MDK; human.
DR   GenomeRNAi; 199920; -.
DR   Pharos; Q5VWT5; Tbio.
DR   PRO; PR:Q5VWT5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5VWT5; protein.
DR   Bgee; ENSG00000187889; Expressed in right uterine tube and 120 other tissues.
DR   Genevisible; Q5VWT5; HS.
DR   GO; GO:0001772; C:immunological synapse; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB.
DR   InterPro; IPR043443; FYB1/2-like.
DR   InterPro; IPR029294; hSH3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR16830; PTHR16830; 1.
DR   Pfam; PF14603; hSH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Membrane; Phosphoprotein; Reference proteome;
KW   SH3 domain.
FT   CHAIN           1..728
FT                   /note="FYN-binding protein 2"
FT                   /id="PRO_0000304583"
FT   DOMAIN          664..724
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          17..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          250..287
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          367..390
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           521..524
FT                   /note="SH2-binding; to LCP2"
FT                   /evidence="ECO:0000269|PubMed:27335501"
FT   COMPBIAS        39..76
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        253..267
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        271..286
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        375..390
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         491
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:27335501"
FT   MOD_RES         587
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:27335501"
FT   VAR_SEQ         355..358
FT                   /note="PTYE -> RRCL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028031"
FT   VAR_SEQ         359..728
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028032"
FT   VARIANT         125
FT                   /note="I -> M (in dbSNP:rs17114336)"
FT                   /id="VAR_035041"
FT   MUTAGEN         491
FT                   /note="Y->F: Decrease in phosphorylation and interaction
FT                   with LCP2. Significant decrease in phosphorylation and loss
FT                   of interaction with LCP2; when associated with F-587."
FT                   /evidence="ECO:0000269|PubMed:27335501"
FT   MUTAGEN         587
FT                   /note="Y->F: Decrease in phosphorylation and interaction
FT                   with LCP2. Significant decrease in phosphorylation and loss
FT                   of interaction with LCP2; when associated with F-491."
FT                   /evidence="ECO:0000269|PubMed:27335501"
FT   CONFLICT        103
FT                   /note="C -> R (in Ref. 3; CAH56148)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        400
FT                   /note="K -> R (in Ref. 3; CAH56148)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        718
FT                   /note="H -> R (in Ref. 3; CAH56148)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   728 AA;  82070 MW;  A98C37E6A0B7F2F9 CRC64;
     MEGEGVRNFK ELRAKFQNLD APPLPGPIKF PAGVSPKGDI GGTQSTQILA NGKPLSSNHK
     QRTPYCSSSE SQPLQPQKIK LAQKSEIPKC SNSPGPLGKS TVCSATSSQK ASLLLEVTQS
     NVEIITKEKV MVANSFRNKL WNWEKVSSQK SEMSSALLLA NYGSKAIHLE GQKGMGLTPE
     EPRKKLETKG AQTLPSQKHV VAPKILHNVS EDPSFVISQH IRKSWENPPP ERSPASSPCQ
     PIYECELASQ APEKQPDVRH HHLPKTKPLP SIDSLGPPPP KPSRPPIVNL QAFQRQPAAV
     PKTQGEVTVE EGSLSPERLF NAEFEEPHNY EATISYLRHS GNSINLCTAK EIADPTYEVG
     IEELQKPGKN FPYPEPSAKH EDKKMKEKQP CELKPKNTEK EPYSNHVFKV DACEGTPEKI
     QMTNVHTGRR NMLAGKQEAM IDIIQTNPCP EGPKLARHSQ GHCGHLEVLE STKETPDLGV
     SKTSSISEEI YDDVEYSRKE VPKLNYSSSL ASSSEENREL YEDVYKTKNN YPKIDLDGKE
     ALKRLQQFFK KEKDRFKIKK TKSKENLSAF SILLPDLELK SQEVIIYDDV DLSEKESKDE
     DKLKMWKPKF LTPKEKKEKN GAEESESFSP RNFFKTKKQN LEKNRMKREE KLFRERFKYD
     KEIIVINTAV ACSNNSRNGI FDLPISPGEE LEVIDTTEQN LVICRNSKGK YGYVLIEHLD
     FKHQSWSP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024